Pacific Biosciences of California Inc (NASDAQ: PACB) is -79.92% lower on its value in year-to-date trading and has touched a low of $1.16 and a high of $10.65 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PACB stock was last observed hovering at around $1.93 in the last trading session, with the day’s gains setting it 0.04%.
Currently trading at $1.97, the stock is -0.27% and -1.95% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 10.83 million and changing 2.07% at the moment leaves the stock -2.47% off its SMA200. PACB registered -79.82% loss for a year compared to 6-month gain of 35.86%. The firm has a 50-day simple moving average (SMA 50) of $2.0096 and a 200-day simple moving average (SMA200) of $2.0201.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 14.53% loss in the last 1 month and extending the period to 3 months gives it a 13.22%, and is 0.51% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.30% over the week and 9.97% over the month.
Pacific Biosciences of California Inc (PACB) has around 796 employees, a market worth around $550.69M and $173.15M in sales. Profit margin for the company is -227.69%. Distance from 52-week low is 69.83% and -81.50% from its 52-week high. The company has generated returns on investments over the last 12 months (-28.92%).
with sales reaching $40.66M over the same period.The EPS is expected to shrink by -12.49% this year, but quarterly earnings will post -22.46% year-over-year. Quarterly sales are estimated to shrink -30.33% in year-over-year returns.
Pacific Biosciences of California Inc (PACB) Top Institutional Holders
319.0 institutions hold shares in Pacific Biosciences of California Inc (PACB), with institutional investors hold 93.21% of the company’s shares. The shares outstanding are 273.81M, and float is at 241.81M with Short Float at 22.49%. Institutions hold 84.53% of the Float.
The top institutional shareholder in the company is ARK INVESTMENT MANAGEMENT LLC with over 33.21 million shares valued at $45.5 million. The investor’s holdings represent 12.3202% of the PACB Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 26.0 million shares valued at $35.62 million to account for 9.6443 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 23.61 million shares representing 8.7576% and valued at over $32.34 million, while MADRONE ADVISORS, LLC holds 8.6772 of the shares totaling 23.39 million with a market value of $32.05 million.
Pacific Biosciences of California Inc (PACB) Insider Activity
The most recent transaction is an insider sale by Kim Susan G. SEC filings show that Kim Susan G. sold 19,782 shares of the company’s common stock on Sep 30 ’24 at a price of $1.72 per share for a total of $34065.0. Following the sale, the insider now owns 0.7 million shares.
Still, SEC filings show that on Sep 16 ’24, HENRY CHRISTIAN O () disposed off 98,907 shares at an average price of $1.75 for $0.17 million. The insider now directly holds 2,497,763 shares of Pacific Biosciences of California Inc (PACB).
